CDKL3 and prostate carcinoma: Validation experiments showed that both CDKL3 knockdown lentivirus (shCDKL3) as well as control lentivirus (shCtrl) could efficiently infect prostate cancer cells (Figure S1) and knockdown the mRNA as well as protein levels of CDKL3 (Fig. 2A).